Clinical trials
Cicatrix trials in the United States with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
100 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2008 | 3 |
| 2009 | 6 |
| 2010 | 2 |
| 2011 | 4 |
| 2012 | 5 |
| 2013 | 9 |
| 2014 | 5 |
| 2015 | 5 |
| 2016 | 5 |
| 2017 | 7 |
| 2018 | 4 |
| 2019 | 5 |
| 2020 | 4 |
| 2021 | 6 |
| 2022 | 7 |
| 2023 | 7 |
| 2024 | 7 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 53 |
| Withdrawn | 11 |
| Unknown status | 9 |
| Recruiting | 8 |
| Terminated | 8 |
| Active, not recruiting | 7 |
| Enrolling by invitation | 2 |
| Suspended | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of California, Davis | 11 |
| Massachusetts General Hospital | 6 |
| Cutera Inc. | 5 |
| Cynosure, Inc. | 5 |
| MiMedx Group, Inc. | 4 |
| University of Miami | 4 |
| AVAVA, Inc. | 3 |
| Baylor College of Medicine | 2 |
| Columbia University | 2 |
| Medstar Health Research Institute | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cicatrix | 100 |
| Surgical Wound | 10 |
| Burns | 7 |
| Cicatrix, Hypertrophic | 6 |
| Hypertrophy | 6 |
| Keloid | 6 |
| Acne Vulgaris | 5 |
| Cutis Laxa | 5 |
| Striae Distensae | 4 |
| Breast Neoplasms | 2 |
Trials
Showing 1 to 25 of 100. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.